TWD
SRPT icon

True Wealth Design’s Sarepta Therapeutics SRPT Stock Holding History

True Wealth Design’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.04K Sell
392
-451
-53% -$8.53K ﹤0.01% 1186
2026
Q1 		$18.3K Sell
843
-208
-20% -$4.03K 0.01% 751
2025
Q4 		$22.6K Buy
1,051
+701
+200% +$14.8K 0.01% 570
2025
Q3 		$6.75K Buy
350
+340
+3,400% +$6.06K ﹤0.01% 975
2025
Q2 		$171 Buy
10
+5
+100% +$213 ﹤0.01% 2116
2025
Q1 		$320 Buy
5
+2
+67% +$211 ﹤0.01% 1741
2024
Q4 		$365 Sell
3
-1
-25% -$123 ﹤0.01% 1146
2024
Q3 		$500 Buy
4
+1
+33% +$138 ﹤0.01% 1099
2024
Q2 		$474 Buy
+3
New +$385 ﹤0.01% 659

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

True Wealth Design's SRPT Position: Q2 2026 in Review

True Wealth Design reduced its Sarepta Therapeutics (SRPT) stake by 53% in Q2 2026, selling an estimated $8.53K and leaving 392 shares worth $7.04K. The position accounts for ﹤0.01% of the portfolio, ranked #1186.

True Wealth Design first reported a position in SRPT in Q2 2024 and has held it in 9 quarters since. The position peaked at $22.6K in Q4 2025. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • True Wealth Design held 392 shares of Sarepta Therapeutics worth $7.04K as of Q2 2026.
  • True Wealth Design sold 451 Sarepta Therapeutics shares in Q2 2026, an estimated $8.53K.
  • Sarepta Therapeutics made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #1186 holding.
  • True Wealth Design first reported a position in Sarepta Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • True Wealth Design's Sarepta Therapeutics position peaked at $22.6K in Q4 2025.
  • 323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.